海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2014年
19期
2819-2821
,共3页
姚强%闵科%邓建良%许春妮%金俊
姚彊%閔科%鄧建良%許春妮%金俊
요강%민과%산건량%허춘니%금준
唑来膦酸%胃肿瘤%血管内皮生长因子
唑來膦痠%胃腫瘤%血管內皮生長因子
서래련산%위종류%혈관내피생장인자
Zoledronic acid%Gastric cancer%VEGF
目的:研究唑来膦酸对胃癌细胞株SGC-7901的体外增殖抑制作用及对血管内皮生长因子(VEGF)的影响。方法采用CCK-8试验检测唑来膦酸对胃癌细胞株SGC-7901的生长抑制作用;酶联免疫吸附试验(ELISA)和半定量RT-PCR法检测药物对VEGF表达水平的变化。结果0.2~3.2μg/L的唑来膦酸能显著抑制SGC-7901细胞的增殖,且具有时间及剂量依赖性,不同药物浓度作用后,胃癌细胞株VEGF的蛋白及基因表达水平均明显降低(P<005),具有浓度依赖性。结论唑来膦酸能抑制胃癌细胞株SGC-7901的生长增殖,其作用机制可能为下调VEGF表达。
目的:研究唑來膦痠對胃癌細胞株SGC-7901的體外增殖抑製作用及對血管內皮生長因子(VEGF)的影響。方法採用CCK-8試驗檢測唑來膦痠對胃癌細胞株SGC-7901的生長抑製作用;酶聯免疫吸附試驗(ELISA)和半定量RT-PCR法檢測藥物對VEGF錶達水平的變化。結果0.2~3.2μg/L的唑來膦痠能顯著抑製SGC-7901細胞的增殖,且具有時間及劑量依賴性,不同藥物濃度作用後,胃癌細胞株VEGF的蛋白及基因錶達水平均明顯降低(P<005),具有濃度依賴性。結論唑來膦痠能抑製胃癌細胞株SGC-7901的生長增殖,其作用機製可能為下調VEGF錶達。
목적:연구서래련산대위암세포주SGC-7901적체외증식억제작용급대혈관내피생장인자(VEGF)적영향。방법채용CCK-8시험검측서래련산대위암세포주SGC-7901적생장억제작용;매련면역흡부시험(ELISA)화반정량RT-PCR법검측약물대VEGF표체수평적변화。결과0.2~3.2μg/L적서래련산능현저억제SGC-7901세포적증식,차구유시간급제량의뢰성,불동약물농도작용후,위암세포주VEGF적단백급기인표체수평균명현강저(P<005),구유농도의뢰성。결론서래련산능억제위암세포주SGC-7901적생장증식,기작용궤제가능위하조VEGF표체。
Objective To investigate the proliferation inhibition function of zoledronic acid on human gas-tric cancer cell SGC-7901 and its influence on vascular endothelial growth factor (VEGF). Methods CCK-8 cell vi-ability assay was performed to investigate the effect of zoledronic acid on cell proliferation. The expression of VEGF was examined by ELISA and semi-quantitative RT-PCR. Results Zoledronic acid inhibited the proliferation of SGC-7901 cells at a dose-and-time dependent manner (concentration range: 0.2~3.2μg/L). Meanwhile, ELISA and semi-quantitative RT-PCR results showed that the expression of VEGF was down-regulated at a dose-dependent fash-ion in SGC-7901 cells. Conclusion Zoledronic acid might inhibit the proliferation of SGC-7901 cells through down-regulation of VEGF.